So I kept it dead simple
Frontiers in Pharmacology, 14, 1063033
Weight loss injections have become increasingly prevalent in clinical practice, with glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) leading the therapeutic landscape
Initially, GLP-1 medication was only for treating diabetes because one of the main roles of GLP-1 is to boost the bodys insulin production
This last point is critical because food and beverages can interfere with the mucosal absorption of semaglutide, significantly reducing bioavailability
Lipotropic injections arent required, but many White Plains patients choose to add them to help maintain energy, protect metabolism, and support overall results while using GLP-1 medications